Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiner Wiest

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Scandinavian Journal of Gastroenterology|December 1, 2010
Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantationGabi I Kirchner, Marcus N Scherer, Aiman Obed, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety studyJordi Bruix, Won-Young Tak, Antonio Gasbarrini, et al.
Gut|February 5, 2013
Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's diseaseAna Gutiérrez, Michael Scharl, Laura Sempere, et al.
Journal of Hepatology|August 17, 2019
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis developmentJuliette Mouries, Paola Brescia, Alessandra Silvestri, et al.
Experimental and Molecular Pathology|August 16, 2011
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitroSabrina Bauer, Thomas S Weiss, Reiner Wiest, et al.
World Journal of Gastroenterology|December 17, 2008
Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patientsMichiel P C Siroen, Reiner Wiest, Milan C Richir, et al.
Clinical Endocrinology|June 30, 2009
Systemic chemerin is related to inflammation rather than obesity in type 2 diabetesJohanna Weigert, Markus Neumeier, Josef Wanninger, et al.
Zeitschrift Fur Gastroenterologie|May 7, 2019
[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)]Alexander L Gerbes, Joachim Labenz, Beate Appenrodt, et al.
Zeitschrift Fur Gastroenterologie|May 26, 2019
[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)]Alexander L Gerbes, Joachim Labenz, Beate Appenrodt, et al.
Gastrointestinal Endoscopy|February 18, 2021
Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approachAnsgar Deibel, Lu Deng, Chih-Yuan Cheng, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Scandinavian Journal of Gastroenterology|December 1, 2010
Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantationGabi I Kirchner, Marcus N Scherer, Aiman Obed, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety studyJordi Bruix, Won-Young Tak, Antonio Gasbarrini, et al.
Gut|February 5, 2013
Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's diseaseAna Gutiérrez, Michael Scharl, Laura Sempere, et al.
Journal of Hepatology|August 17, 2019
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis developmentJuliette Mouries, Paola Brescia, Alessandra Silvestri, et al.
Experimental and Molecular Pathology|August 16, 2011
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitroSabrina Bauer, Thomas S Weiss, Reiner Wiest, et al.
World Journal of Gastroenterology|December 17, 2008
Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patientsMichiel P C Siroen, Reiner Wiest, Milan C Richir, et al.
Clinical Endocrinology|June 30, 2009
Systemic chemerin is related to inflammation rather than obesity in type 2 diabetesJohanna Weigert, Markus Neumeier, Josef Wanninger, et al.
Zeitschrift Fur Gastroenterologie|May 7, 2019
[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)]Alexander L Gerbes, Joachim Labenz, Beate Appenrodt, et al.
Zeitschrift Fur Gastroenterologie|May 26, 2019
[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)]Alexander L Gerbes, Joachim Labenz, Beate Appenrodt, et al.
Gastrointestinal Endoscopy|February 18, 2021
Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approachAnsgar Deibel, Lu Deng, Chih-Yuan Cheng, et al.
Pageof 12